Glaukos Corp

GKOSNYSE · USD
163.81USD0.00 (+1.49%)
3510

Glaukos Corp (GKOS) Wheel Strategy

GKOS wheel strategy scan found 72 cash-secured put setups on the previous trading day. Probability of expiring worthless is above 50%. Annualized returns reach up to 393.5%.

Read more

Running a GKOS wheel strategy lets you generate consistent premium income on Glaukos Corp while setting your own entry and exit prices on the underlying. Glaukos Corp's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own GKOS, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best GKOS wheel strategy setups in real time.

The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on GKOS, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable GKOS wheel from a losing one.

Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite, a three stents product that is designed for use as a standalone procedure in patients with refractory glaucoma; and iDose TR, a targeted injectable implant based on its micro-scale device-platform that is designed to deliver therapeutic levels of medication.

The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in San Clemente, California.

The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the GKOS wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your GKOS wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.

Sep 18, 2026160.00$0.05$1.73-0.40110%67.3%393.5%47
Oct 16, 2026160.00$6.00$7.20-0.442910%51.2%56.6%285
Oct 16, 2026155.00$3.50$5.15-0.342910%61.1%41.8%15
Nov 20, 2026155.00$9.50$11.20-0.376410%56.2%41.2%0
Nov 20, 2026150.00$7.50$9.15-0.326410%63.0%34.8%0
Dec 18, 2026155.00$11.10$12.75-0.379210%54.4%32.6%0
Nov 20, 2026145.00$5.50$7.30-0.276410%69.5%28.7%0
Dec 18, 2026150.00$8.90$10.70-0.339210%60.0%28.3%601
Oct 16, 2026150.00$1.70$3.35-0.252910%70.5%28.1%463
Jan 15, 2027155.00$12.40$14.15-0.3712010%53.1%27.8%2

As of September 18, 2026

Run the Wheel on GKOS With Confidence

Find the best GKOS wheel strategy setups across strikes and expirations, plan ahead with at-strike values, and keep your covered calls and puts on track.

Start your 14-day free trial